Biodexa Pharmaceuticals Plc SEC filings BDRX
Biodexa Pharmaceuticals Plc has 731 filings in SEC EDGAR's recent list, going back to Jun 4, 2015. Its latest annual report, Form 20-F, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 14, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 14, 2026 | Oct 14, 2026 |
| 424B3 | Prospectus | Oct 14, 2026 | — |
| 424B3 | Prospectus | Oct 14, 2026 | — |
| 424B3 | Prospectus | Oct 14, 2026 | — |
| 424B3 | Prospectus | Oct 14, 2026 | — |
| 424B3 | Prospectus | Oct 14, 2026 | — |
| 424B3 | Prospectus | Oct 14, 2026 | — |
| 424B3 | Prospectus | Oct 14, 2026 | — |
| 424B3 | Prospectus | Oct 14, 2026 | — |
| 6-K | Current report (foreign issuer) | Oct 8, 2026 | Oct 8, 2026 |
| 424B3 | Prospectus | Oct 6, 2026 | — |
| EFFECT | Filing | Sep 30, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Sep 24, 2026 | — |
| 424B3 | Prospectus | Sep 15, 2026 | — |
| 424B3 | Prospectus | Sep 15, 2026 | — |
| 424B3 | Prospectus | Sep 15, 2026 | — |
| 424B3 | Prospectus | Sep 15, 2026 | — |
| 424B3 | Prospectus | Sep 15, 2026 | — |
| 424B3 | Prospectus | Sep 15, 2026 | — |
| 424B3 | Prospectus | Sep 15, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 15, 2026 | Sep 15, 2026 |
| 424B3 | Prospectus | Sep 11, 2026 | — |
| 424B3 | Prospectus | Sep 11, 2026 | — |
| 424B3 | Prospectus | Sep 11, 2026 | — |
| 424B3 | Prospectus | Sep 11, 2026 | — |
| 424B3 | Prospectus | Sep 11, 2026 | — |
| 424B3 | Prospectus | Sep 11, 2026 | — |
| 424B3 | Prospectus | Sep 11, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 11, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 424B3 | Prospectus | Aug 5, 2026 | — |
| 424B3 | Prospectus | Aug 5, 2026 | — |
| 424B3 | Prospectus | Aug 5, 2026 | — |
| 424B3 | Prospectus | Aug 5, 2026 | — |
| 424B3 | Prospectus | Aug 5, 2026 | — |
| 424B3 | Prospectus | Aug 5, 2026 | — |
| 424B3 | Prospectus | Aug 4, 2026 | — |
| EFFECT | Filing | Aug 3, 2026 | — |
| F-1/A | Amendment no. 1 | Jul 30, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 29, 2026 | Jul 29, 2026 |
| F-1 | Registration statement (foreign issuer) | Jul 15, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 9, 2026 | Jul 9, 2026 |
| 424B3 | Prospectus | Jul 1, 2026 | — |
| 424B3 | Prospectus | Jul 1, 2026 | — |
| 424B3 | Prospectus | Jul 1, 2026 | — |
| 424B3 | Prospectus | Jul 1, 2026 | — |
| 424B3 | Prospectus | Jul 1, 2026 | — |
| 424B3 | Prospectus | Jul 1, 2026 | — |
| 424B5 | Prospectus supplement | Jul 1, 2026 | — |
| 6-K/A | Amendment no. 1 | Jul 1, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 17, 2026 | Jun 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 6-K | Current report (foreign issuer) | May 14, 2026 | May 14, 2026 |
| 424B3 | Prospectus | Apr 2, 2026 | — |
| 424B3 | Prospectus | Apr 2, 2026 | — |
| 424B3 | Prospectus | Apr 2, 2026 | — |
| 424B3 | Prospectus | Apr 2, 2026 | — |
| 424B3 | Prospectus | Apr 2, 2026 | — |
| 424B3 | Prospectus | Apr 2, 2026 | — |
| EFFECT | Filing | Mar 30, 2026 | — |
| EFFECT | Filing | Mar 30, 2026 | — |
| EFFECT | Filing | Mar 30, 2026 | — |
| EFFECT | Filing | Mar 30, 2026 | — |
| EFFECT | Filing | Mar 30, 2026 | — |
| EFFECT | Filing | Mar 30, 2026 | — |
| POS AM | Amendment no. 2 | Mar 30, 2026 | — |
| POS AM | Amendment no. 1 | Mar 30, 2026 | — |
| POS AM | Amendment no. 2 | Mar 30, 2026 | — |
| POS AM | Amendment no. 2 | Mar 30, 2026 | — |
| POS AM | Amendment no. 3 | Mar 30, 2026 | — |
| POS AM | Amendment no. 3 | Mar 30, 2026 | — |
| 20-F | Annual report (foreign issuer) | Mar 27, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 27, 2026 | Mar 27, 2026 |
| 3 | Initial insider ownership | Mar 20, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| 424B3 | Prospectus | Feb 4, 2026 | — |
| 424B3 | Prospectus | Feb 4, 2026 | — |
| 424B3 | Prospectus | Feb 4, 2026 | — |
| 424B3 | Prospectus | Feb 4, 2026 | — |
| 424B3 | Prospectus | Feb 4, 2026 | — |
| 424B3 | Prospectus | Feb 4, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 4, 2026 | Feb 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 20, 2026 | — |
| 424B3 | Prospectus | Jan 6, 2026 | — |
| 424B3 | Prospectus | Jan 6, 2026 | — |
| 424B3 | Prospectus | Jan 6, 2026 | — |
| 424B3 | Prospectus | Jan 6, 2026 | — |
| 424B3 | Prospectus | Jan 6, 2026 | — |
| 424B3 | Prospectus | Jan 6, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 6, 2026 | Jan 6, 2026 |
| 6-K | Current report (foreign issuer) | Jan 5, 2026 | Jan 5, 2026 |
| 424B4 | Prospectus | Dec 19, 2025 | — |
| 424B3 | Prospectus | Dec 18, 2025 | — |
| 424B3 | Prospectus | Dec 18, 2025 | — |
| 424B3 | Prospectus | Dec 18, 2025 | — |
| 424B3 | Prospectus | Dec 18, 2025 | — |
| 424B3 | Prospectus | Dec 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 18, 2025 | Dec 17, 2025 |
| EFFECT | Filing | Dec 17, 2025 | — |
| CORRESP | Letter to the SEC | Dec 17, 2025 | — |
| CORRESP | Letter to the SEC | Dec 17, 2025 | — |
| F-1/A | Amendment no. 2 | Dec 11, 2025 | — |
| F-1/A | Amendment no. 1 | Dec 8, 2025 | — |
| 424B3 | Prospectus | Nov 24, 2025 | — |
| 424B3 | Prospectus | Nov 24, 2025 | — |
| EFFECT | Filing | Nov 21, 2025 | — |
| EFFECT | Filing | Nov 21, 2025 | — |
| POS AM | Amendment no. 2 | Nov 17, 2025 | — |
| CORRESP | Letter to the SEC | Nov 17, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Nov 17, 2025 | — |
| POS AM | Amendment no. 2 | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 424B3 | Prospectus | Nov 3, 2025 | — |
| 424B3 | Prospectus | Nov 3, 2025 | — |
| 424B3 | Prospectus | Nov 3, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 3, 2025 | Nov 3, 2025 |
| EFFECT | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 26, 2025 | — |
| 424B3 | Prospectus | Sep 12, 2025 | — |
| 424B3 | Prospectus | Sep 12, 2025 | — |
| 424B3 | Prospectus | Sep 12, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 12, 2025 | Jun 30, 2025 |
| UPLOAD | Letter from the SEC | Aug 20, 2025 | — |
| CORRESP | Letter to the SEC | Aug 19, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2025 | — |
| 424B3 | Prospectus | Aug 18, 2025 | — |
| 424B3 | Prospectus | Aug 18, 2025 | — |
| 424B3 | Prospectus | Aug 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 18, 2025 | Aug 18, 2025 |
| 424B3 | Prospectus | Aug 6, 2025 | — |
| 424B3 | Prospectus | Aug 6, 2025 | — |
| 424B3 | Prospectus | Aug 6, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 31, 2025 | Jul 31, 2025 |
| 424B3 | Prospectus | Jul 18, 2025 | — |
| 424B3 | Prospectus | Jul 18, 2025 | — |
| 424B3 | Prospectus | Jul 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 15, 2025 | Jul 15, 2025 |
| 424B3 | Prospectus | Jun 27, 2025 | — |
| 424B3 | Prospectus | Jun 27, 2025 | — |
| 424B3 | Prospectus | Jun 27, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 27, 2025 | Jun 27, 2025 |
| 424B3 | Prospectus | Jun 13, 2025 | — |
| 424B3 | Prospectus | Jun 13, 2025 | — |
| 424B3 | Prospectus | Jun 13, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 13, 2025 | Jun 13, 2025 |
| 6-K | Current report (foreign issuer) | Jun 11, 2025 | Jun 11, 2025 |
| 6-K | Current report (foreign issuer) | Jun 4, 2025 | Jun 4, 2025 |
| 424B3 | Prospectus | Jun 2, 2025 | — |
| 424B3 | Prospectus | Jun 2, 2025 | — |
| 424B3 | Prospectus | May 30, 2025 | — |
| 6-K | Current report (foreign issuer) | May 30, 2025 | May 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 28, 2025 | — |
| 6-K | Current report (foreign issuer) | May 23, 2025 | May 23, 2025 |
| 424B3 | Prospectus | May 23, 2025 | — |
| 424B3 | Prospectus | May 23, 2025 | — |
| 424B3 | Prospectus | May 23, 2025 | — |
| 6-K | Current report (foreign issuer) | May 22, 2025 | May 22, 2025 |
| 6-K | Current report (foreign issuer) | May 22, 2025 | May 22, 2025 |
| 424B3 | Prospectus | May 15, 2025 | — |
| 424B3 | Prospectus | May 15, 2025 | — |
| 424B3 | Prospectus | May 15, 2025 | — |
| 6-K | Current report (foreign issuer) | May 15, 2025 | May 15, 2025 |
| 6-K | Current report (foreign issuer) | May 12, 2025 | May 12, 2025 |
| 424B3 | Prospectus | May 12, 2025 | — |
| 424B3 | Prospectus | May 12, 2025 | — |
| 424B3 | Prospectus | May 12, 2025 | — |
| EFFECT | Filing | May 9, 2025 | — |
| EFFECT | Filing | May 9, 2025 | — |
| EFFECT | Filing | May 9, 2025 | — |
| UPLOAD | Letter from the SEC | May 9, 2025 | — |
| POS AM | 333-281489 amendment no. 1 | May 8, 2025 | — |
| POS AM | 333-279994 amendment no. 1 | May 8, 2025 | — |
| 6-K | Current report (foreign issuer) | May 2, 2025 | May 2, 2025 |
| DRSLTR | Filing | May 1, 2025 | — |
| DRS | Filing | May 1, 2025 | — |
| POS AM | Amendment no. 1 | Apr 29, 2025 | — |
| 6-K | Current report (foreign issuer) | Apr 17, 2025 | Apr 17, 2025 |
| 20-F | Annual report (foreign issuer) | Apr 11, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Apr 11, 2025 | Apr 11, 2025 |
| 6-K | Current report (foreign issuer) | Mar 10, 2025 | Mar 10, 2025 |
| 6-K | Current report (foreign issuer) | Mar 6, 2025 | Mar 6, 2025 |
| 6-K | Current report (foreign issuer) | Feb 24, 2025 | Feb 24, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Feb 13, 2025 | Feb 13, 2025 |
| 6-K | Current report (foreign issuer) | Feb 10, 2025 | Feb 10, 2025 |
| 424B3 | Prospectus | Jan 28, 2025 | — |
| EFFECT | Filing | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 23, 2025 | — |
| 6-K | Current report (foreign issuer) | Jan 22, 2025 | Jan 22, 2025 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BDRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Cardiff
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1643918
- Former names
- Midatech Pharma Plc (until Mar 27, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.